(Q79447601)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

main subject

phase I clinical trial

1 reference

based on heuristic

inferred from title

mucopolysaccharidosis II

1 reference

Joseph Muenzer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Muge Gucsavas-Calikoglu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Shawn E McCandless

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Thomas J Schuetz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Alan Kimura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

20 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

Molecular Genetics and Metabolism

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

329-337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

The Relative Frequency of the Hurler and Hunter Syndromes

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Prevalence of lysosomal storage disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Incidence of Hunter's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Molecular analysis in 23 Hunter disease families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: identification of 13 novel mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Molecular and phenotypic variation in patients with severe Hunter syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Mutation analysis in 57 unrelated patients with MPS II (Hunter's disease)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Long-term follow-up following bone marrow transplantation for Hunter disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Lysosomal Storage Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Bone marrow transplantation in Hunter syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Enzyme-replacement therapy in mucopolysaccharidosis I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, o

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Liver and spleen volumetry with quantitative MR imaging and dual-space clustering segmentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Volume of the spleen in children as measured on CT scans: normal standards as a function of body weight

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Practice Parameters for the Indications for Polysomnography and Related Procedures: An Update for 2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

7 January 2021

Obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Adult criteria for obstructive sleep apnea do not identify children with serious obstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2006.09.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMGME.2006.09.001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185020%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference